The gut microbiota as a target to control hyperuricemia pathogenesis: Potential mechanisms and therapeutic strategies

References

• Backhed, F., R. E. Ley, J. L. Sonnenburg, D. A. Peterson, and J. I. Gordon. 2005. Host-bacterial mutualism in the human intestine. Science (New York, N.Y.) 307 (5717):1915–20. doi: 10.1126/science.1104816.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., J. Amar, M. A. Iglesias, M. Poggi, C. Knauf, D. Bastelica, A. M. Neyrinck, F. Fava, K. M. Tuohy, C. Chabo, et al. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (7):1761–72. doi: 10.2337/db06-1491.
   PubMed Web of Science ®Google Scholar
• Cao, T., X. Li, T. Mao, H. Liu, Q. Zhao, X. Ding, C. Li, L. Zhang, and Z. Tian. 2017. Probiotic therapy alleviates hyperuricemia in C57BL/6 mouse model. Biomedical Research – India 28 (5):2244–9.
   Google Scholar
• Chen, R. J., M. H. Chen, Y. L. Chen, C. M. Hsiao, H. M. Chen, S. J. Chen, M. D. Wu, Y. J. Yech, G. F. Yuan, and Y. J. Wang. 2017. Evaluating the urate-lowering effects of different microbial fermented extracts in hyperuricemic models accompanied with a safety study. Journal of Food and Drug Analysis 25 (3):597–606. doi: 10.1016/j.jfda.2016.07.003.
   PubMed Web of Science ®Google Scholar
• Choi, H. K. 2010. A prescription for lifestyle change in patients with hyperuricemia and gout. Current Opinion in Rheumatology 22 (2):165–72. doi: 10.1097/BOR.0b013e328335ef38.
   PubMed Web of Science ®Google Scholar
• Crane, J. K. 2013. Role of host xanthine oxidase in infection due to enteropathogenic and Shiga-toxigenic Escherichia coli. Gut Microbes 4 (5):388–91. doi: 10.4161/gmic.25584.
   PubMed Web of Science ®Google Scholar
• Crane, J. K., and K. M. Mongiardo. 2014. Pro-inflammatory effects of uric acid in the gastrointestinal tract. Immunological Investigations 43 (3):255–66. doi: 10.3109/08820139.2013.864667.
   PubMed Web of Science ®Google Scholar
• de Oliveira, E. P., and R. C. Burini. 2012. High plasma uric acid concentration: Causes and consequences. Diabetology & Metabolic Syndrome 4:12. doi: 10.1186/1758-5996-4-12.
   Web of Science ®Google Scholar
• Debosch, B. J., O. Kluth, H. Fujiwara, A. Schürmann, and K. Moley. 2014. Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9. Nature Communications 5:4642. doi: 10.1038/ncomms5642.
   PubMed Web of Science ®Google Scholar
• Ekpenyong, C. E., and N. Daniel. 2015. Roles of diets and dietary factors in the pathogenesis, management and prevention of abnormal serum uric acid levels. Pharmanutrition 3 (2):29–45. doi: 10.1016/j.phanu.2014.12.001.
   Google Scholar
• Garcia-Arroyo, F. E., G. Gonzaga, I. Munoz-Jimenez, M. G. Blas-Marron, O. Silverio, E. Tapia, V. Soto, N. Ranganathan, P. Ranganathan, U. Vyas, et al. 2018. Probiotic supplements prevented oxonic acid-induced hyperuricemia and renal damage. Plos One 13 (8):e0202901. doi: 10.1371/journal.pone.0202901.
   PubMed Web of Science ®Google Scholar
• Gareau, M. G., P. M. Sherman, and W. A. Walker. 2010. Probiotics and the gut microbiota in intestinal health and disease. Nature Reviews. Gastroenterology & Hepatology 7 (9):503–14. doi: 10.1038/nrgastro.2010.117.
   PubMed Web of Science ®Google Scholar
• Guo, L.-F., X. Chen, S.-S. Lei, B. Li, N.-Y. Zhang, H.-Z. Ge, K. Yang, G.-Y. Lv, and S.-H. Chen. 2020. Effects and mechanisms of Dendrobium officinalis six nostrum for treatment of hyperuricemia with hyperlipidemia. Evidence-Based Complementary and Alternative Medicine: eCAM 2020 (4):2914019. doi: 10.1155/2020/2914019.
   PubMedGoogle Scholar
• Guo, Z., J. Zhang, Z. Wang, K. Y. Ang, S. Huang, Q. Hou, X. Su, J. Qiao, Y. Zheng, L. Wang, et al. 2016. Intestinal microbiota distinguish gout patients from healthy humans. Scientific Reports 6:20602. doi: 10.1038/srep20602.
   PubMed Web of Science ®Google Scholar
• Han, B., M. Gong, Z. Li, Y. Qiu, and Z. Zou. 2020. NMR-based metabonomic study reveals intervention effects of polydatin on potassium oxonate-induced hyperuricemia in rats. Oxidative Medicine and Cellular Longevity 2020:6943860. doi: 10.1155/2020/6943860.
   PubMed Web of Science ®Google Scholar
• Han, J., X. Wang, S. Tang, C. Lu, H. Wan, J. Zhou, Y. Li, T. Ming, Z. J. Wang, and X. Su. 2020. Protective effects of tuna meat oligopeptides (TMOP) supplementation on hyperuricemia and associated renal inflammation mediated by gut microbiota. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 34 (4):5061–76. doi: 10.1096/fj.201902597RR.
   PubMed Web of Science ®Google Scholar
• Hao, S. J., C. Zhang, and H. Song. 2016. Natural products improving hyperuricemia with hepatorenal dual effects. Evidence-Based Complementary and Alternative Medicine: eCAM 2016:7390504. doi: 10.1155/2016/7390504.
   PubMed Web of Science ®Google Scholar
• Hartwich, K., A. Poehlein, and R. Daniel. 2012. The purine-utilizing bacterium Clostridium acidurici 9a: A genome-guided metabolic reconsideration. Plos One 7 (12):e51662. doi: 10.1371/journal.pone.0051662.
   PubMed Web of Science ®Google Scholar
• Husseini, N. E., O. Kaskar, and L. B. Goldstein. 2014. Chronic kidney disease and stroke. Advances in Chronic Kidney Disease 21 (6):500–8. doi: 10.1053/j.ackd.2014.09.001.
   PubMed Web of Science ®Google Scholar
• Hoon, L. S., P. Gunhyuk, K. S. Bae, and O. Dal-Seok. 2018. Uric acid-lowering effect and intestinal permeability of Kampo medicine, Hachimijiogan, Yokuininto and Goshakusan. European Journal of Integrative Medicine 20:193–9. doi: 10.1016/j.eujim.2018.05.011.
   Web of Science ®Google Scholar
• Hosomi, A., T. Nakanishi, T. Fujita, and I. Tamai. 2012. Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2. Plos One 7 (2):e30456. doi: 10.1371/journal.pone.0030456.
   PubMed Web of Science ®Google Scholar
• Hsieh, C. Y., H. J. Lin, C. H. Chen, C. C. Lai, and Y. H. K. Yang. 2014. Chronic kidney disease and stroke. Lancet Neurology 13 (11):107. doi: 10.1016/S1474-4422(14)70199-1.
   Web of Science ®Google Scholar
• Ichida, K., H. Matsuo, T. Takada, A. Nakayama, K. Murakami, T. Shimizu, Y. Yamanashi, H. Kasuga, H. Nakashima, T. Nakamura, et al. 2012. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nature Communications 3:764. doi: 10.1038/ncomms1756.
   PubMed Web of Science ®Google Scholar
• Jakse, B., B. Jakse, M. Pajek, and J. Pajek. 2019. Uric acid and plant-based nutrition. Nutrients 11 (8):1736. doi: 10.3390/nu11081736.
   Web of Science ®Google Scholar
• Johnson, R. J., G. L. Bakris, C. Borghi, M. B. Chonchol, D. Feldman, M. A. Lanaspa, T. R. Merriman, O. W. Moe, D. B. Mount, L. G. Sanchez Lozada, et al. 2018. Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: Report of a scientific workshop organized by the National Kidney Foundation. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation 71 (6):851–65. doi: 10.1053/j.ajkd.2017.12.009.
   PubMed Web of Science ®Google Scholar
• Jung, S. W., S. M. Kim, Y. G. Kim, S. H. Lee, and J. Y. Moon. 2020. Uric acid and inflammation in kidney disease. American Journal of Physiology. Renal Physiology 318 (6):F1327–40. doi: 10.1152/ajprenal.00272.2019.
   PubMed Web of Science ®Google Scholar
• Kanbay, M., T. Jensen, Y. Solak, M. Le, C. Roncal-Jimenez, C. Rivard, M. A. Lanaspa, T. Nakagawa, and R. J. Johnson. 2016. Uric acid in metabolic syndrome: From an innocent bystander to a central player. European Journal of Internal Medicine 29:3–8. doi: 10.1016/j.ejim.2015.11.026.
   PubMed Web of Science ®Google Scholar
• Kang, D. H., and W. Chen. 2011. Uric acid and chronic kidney disease: New understanding of an old problem. Seminars in Nephrology 31 (5):447–52. doi: 10.1016/j.semnephrol.2011.08.009.
   PubMed Web of Science ®Google Scholar
• Karlsson, J. L., and H. A. Barker. 1949. Tracer experiments on the mechanism of uric acid decomposition and acetic acid synthesis by Clostridium-acidi-urici. Journal of Biological Chemistry 178 (2):891–902. doi: 10.1016/S0021-9258(18)56908-8.
   PubMed Web of Science ®Google Scholar
• Kayagaki, N., M. T. Wong, I. B. Stowe, S. R. Ramani, L. C. Gonzalez, S. Akashi-Takamura, K. Miyake, J. Zhang, W. P. Lee, A. Muszynski, et al. 2013. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science (New York, N.Y.) 341 (6151):1246–9. doi: 10.1126/science.1240248.
   PubMed Web of Science ®Google Scholar
• Kunitskaia, N. A., L. S. Kozina, A. K. Utkin, and A. A. Utkina. 2013. The peculiarities of chronic inflammation in elderly patients with gout and metabolic syndrome. Advances in Gerontology = Uspekhi Gerontologii 26 (1):161–5.
   PubMedGoogle Scholar
• Li, D., P. Wang, P. Wang, X. Hu, and F. Chen. 2016. The gut microbiota: A treasure for human health. Biotechnology Advances 34 (7):1210–24. doi: 10.1016/j.biotechadv.2016.08.003.
   PubMed Web of Science ®Google Scholar
• Li, J., F. Zhao, Y. Wang, J. Chen, J. Tao, G. Tian, S. Wu, W. Liu, Q. Cui, B. Geng, et al. 2017. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome 5 (1):14. doi: 10.1186/s40168-016-0222-x.
   PubMed Web of Science ®Google Scholar
• Li, M., D. Yang, L. Mei, L. Yuan, A. Xie, and J. Yuan. 2014. Screening and characterization of purine nucleoside degrading lactic acid bacteria isolated from Chinese sauerkraut and evaluation of the serum uric acid lowering effect in hyperuricemic rats. Plos One. 9 (9):e105577. doi: 10.1371/journal.pone.0105577.
   PubMed Web of Science ®Google Scholar
• Lima, W. G., M. E. S. Martins-Santos, and V. E. Chaves. 2015. Uric acid as a modulator of glucose and lipid metabolism. Biochimie 116:17–23. doi: 10.1016/j.biochi.2015.06.025.
   PubMed Web of Science ®Google Scholar
• Lin, X., T. Shao, L. Huang, X. Wen, M. Wang, C. Wen, and Z. He. 2020. Simiao decoction alleviates gouty arthritis by modulating proinflammatory cytokines and the gut ecosystem. Frontiers in Pharmacology 11:955. doi: 10.3389/fphar.2020.00955.
   PubMed Web of Science ®Google Scholar
• Liu, G., X. F. Chen, X. Lu, J. Y. Zhao, and X. L. Li. 2020. Sunflower head enzymatic hydrolysate relives hyperuricemia by inhibiting crucial proteins (xanthine oxidase, adenosine deaminase, uric acid transporter1) and restoring gut microbiota in mice. Journal of Functional Foods 72:104055. doi: 10.1016/j.jff.2020.104055.
   Web of Science ®Google Scholar
• Liu, X., Q. Lv, H. Ren, L. Gao, P. Zhao, X. Yang, G. Yang, D. Xu, G. Wang, W. Yang, et al. 2020. The altered gut microbiota of high-purine-induced hyperuricemia rats and its correlation with hyperuricemia. PeerJ 8:e8664. doi: 10.7717/peerj.8664.
   PubMed Web of Science ®Google Scholar
• Lohsoonthorn, V., B. Dhanamun, and M. A. Williams. 2006. Prevalence of hyperuricemia and its relationship with metabolic syndromein Thai adults receiving annual health exams. Archives of Medical Research 37 (7):883–9. doi: 10.7717/peerj.8664.
   PubMed Web of Science ®Google Scholar
• Lou, X.-J., Y.-Z. Wang, S.-S. Lei, X. He, T.-T. Lu, L.-H. Zhan, X. Chen, Y.-H. Chen, B. Li, X. Zheng, et al. 2020. Beneficial effects of macroporous resin extract of Dendrobium candidum leaves in rats with hyperuricemia induced by a high-purine diet. Evidence-Based Complementary and Alternative Medicine: eCAM 2020 (10):3086106–10. doi: 10.1155/2020/3086106.
   PubMedGoogle Scholar
• Luissint, A. C., C. A. Parkos, and A. Nusrat. 2016. Inflammation and the intestinal barrier: Leukocyte–epithelial cell interactions, cell junction remodeling, and mucosal repair. Gastroenterology 151 (4):616–32. doi: 10.1053/j.gastro.2016.07.008.
   PubMed Web of Science ®Google Scholar
• Masayuki, H. 2008. Epidemiology of hyperuricemia and gout in Japan. Nihon Rinsho Japanese Journal of Clinical Medicine 66 (4):647–52.
   PubMedGoogle Scholar
• Maiuolo, J., F. Oppedisano, S. Gratteri, C. Muscoli, and V. Mollace. 2016. Regulation of uric acid metabolism and excretion. International Journal of Cardiology 213:8–14. doi: 10.1016/j.ijcard.2015.08.109.
   PubMed Web of Science ®Google Scholar
• Marinello, E., G. Pompucci, and G. Riario-Sforza. 1978. Interrelationship between purine, carbohydrate, lipid and amino acid metabolism, in hyperuricaemia and gout. Quaderni Sclavo di diagnostica clinica e di laboratorio 14 (1):1–25.
   PubMedGoogle Scholar
• Matsuo, H., T. Takada, K. Ichida, T. Nakamura, A. Nakayama, Y. Ikebuchi, K. Ito, Y. Kusanagi, T. Chiba, S. Tadokoro, et al. 2009. Common defects of ABCG2, a high-capacity urate exporter, cause gout: A function-based genetic analysis in a Japanese population. Science Translational Medicine 1 (5):5ra11. doi: 10.1126/scitranslmed.3000237.
   PubMed Web of Science ®Google Scholar
• Mehmood, A., L. Zhao, C. Wang, I. Hossen, R. N. Raka, and H. Zhang. 2020. Correction: Stevia residue extract increases intestinal uric acid excretion via interactions with intestinal urate transporters in hyperuricemic mice. Food & Function 11 (3):2764. doi: 10.1039/d0fo90011g.
   PubMed Web of Science ®Google Scholar
• Mehmood, A., L. Zhao, C. Wang, M. Nadeem, A. Raza, N. Ali, and A. A. Shah. 2019. Management of hyperuricemia through dietary polyphenols as a natural medicament: A comprehensive review. Critical Reviews in Food Science and Nutrition 59 (9):1433–55. doi: 10.1080/10408398.2017.1412939.
   PubMed Web of Science ®Google Scholar
• Michael, C. X., C. Yokose, S. K. Rai, M. H. Pillinger, and H. K. Choi. 2019. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: The national health and nutrition examination survey, 2007–2016. Arthritis & Rheumatology (Hoboken, N.J.) 71 (6):991–9. doi: 10.1002/art.40807.
   PubMed Web of Science ®Google Scholar
• Nakayama, A., H. Matsuo, T. Shimizu, H. Ogata, Y. Takada, H. Nakashima, T. Nakamura, S. Shimizu, T. Chiba, M. Sakiyama, et al. 2013. A common missense variant of monocarboxylate transporter 9 (MCT9/SLC16A9) gene is associated with renal overload gout, but not with all gout susceptibility. Human Cell 26 (4):133–6. doi: 10.1007/s13577-013-0073-8.
   PubMed Web of Science ®Google Scholar
• Nieuwdorp, M., P. W. Gilijamse, N. Pai, and L. M. Kaplan. 2014. Role of the microbiome in energy regulation and metabolism. Gastroenterology 146 (6):1525–33. doi: 10.1053/j.gastro.2014.02.008.
   PubMed Web of Science ®Google Scholar
• Pan, L. B., P. Han, S. R. Ma, R. Peng, C. Wang, W. J. Kong, L. Cong, J. Fu, Z. W. Zhang, H. Yu, et al. 2020. Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia. Acta Pharmaceutica Sinica B 10 (2):249–61. doi: 10.1016/j.apsb.2019.10.007.
   PubMed Web of Science ®Google Scholar
• Pascart, T., and F. Liote. 2019. Gout: State of the art after a decade of developments. Rheumatology (Oxford, England) 58 (1):27–44. doi: 10.1093/rheumatology/key002.
   PubMed Web of Science ®Google Scholar
• Pascart, T., and P. Richette. 2018. Investigational drugs for hyperuricemia, an update on recent developments. Expert Opinion on Investigational Drugs 27 (5):437–44. doi: 10.1080/13543784.2018.1471133.
   PubMed Web of Science ®Google Scholar
• Patel, D., D. Menon, E. Bernfeld, V. Mroz, S. Kalan, D. Loayza, and D. A. Foster. 2016. Aspartate rescues S-phase arrest caused by suppression of glutamine utilization in KRas-driven cancer cells. The Journal of Biological Chemistry 291 (17):9322–9. doi: 10.1074/jbc.M115.710145.
   PubMed Web of Science ®Google Scholar
• Peng, T.-C., C.-C. Wang, T.-W. Kao, J. Y.-H. Chan, Y.-H. Yang, Y.-W. Chang, and W.-L. Chen. 2015. Relationship between hyperuricemia and lipid profiles in US adults. Biomed Research International 2015:1–7. doi: 10.1155/2015/127596.
   Web of Science ®Google Scholar
• Pilemann-Lyberg, S., T. W. Hansen, N. Tofte, S. A. Winther, S. Theilade, T. S. Ahluwalia, and P. Rossing. 2019. Uric acid is an independent risk factor for decline in kidney function, cardiovascular events, and mortality in patients with type 1 diabetes. Diabetes Care 42 (6):1088–94. doi: 10.2337/dc18-2173.
   PubMed Web of Science ®Google Scholar
• Ridi, R. E., and H. Tallima. 2017. Physiological functions and pathogenic potential of uric acid: A review. Journal of Advanced Research 8 (5):487–93. doi: 10.1016/j.jare.2017.03.003.
   PubMed Web of Science ®Google Scholar
• Ronco, C. 2014. Lipopolysaccharide (LPS) from the cellular wall of Gram-negative bacteria, also known as endotoxin, is a key molecule in the pathogenesis of sepsis and septic shock. Blood Purification 37 (s1):1. doi: 10.1159/000357412.
   PubMedGoogle Scholar
• Roxon, J. J., A. J. Ryan, and S. E. Wright. 1966. Reduction of tartrazine by a proteus species isolated from rats. Food and Cosmetics Toxicology 4 (4):419–26. doi: 10.1016/S0015-6264(66)80583-7.
   PubMedGoogle Scholar
• Sakurai, H. 2013. Urate transporters in the genomic era. Current Opinion in Nephrology and Hypertension 22 (5):545–50. doi: 10.1097/MNH.0b013e328363ffc8.
   PubMed Web of Science ®Google Scholar
• Satoru, K., S. Kazumi, Y. Yoko, A. Mihoko, S. Ayumi, T. Kumiko, S. Aki, and S. Hirohito. 2009. Association between serum uric acid and development of type 2 diabetes. Diabetes Care 32 (9):1737–42. doi: 10.2337/dc09-0288.
   PubMed Web of Science ®Google Scholar
• Shao, T. J., L. Shao, H. C. Li, Z. J. Xie, Z. X. He, and C. P. Wen. 2017. Combined signature of the fecal microbiome and metabolome in patients with gout. Frontiers in Microbiology 8:268. doi: 10.3389/fmicb.2017.00268.
   PubMed Web of Science ®Google Scholar
• Smith, P. M., M. R. Howitt, N. Panikov, M. Michaud, C. A. Gallini, M. Bohlooly-Y, J. N. Glickman, and W. S. Garrett. 2013. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science (New York, N.Y.) 341 (6145):569–73. doi: 10.1126/science.1241165.
   PubMed Web of Science ®Google Scholar
• Sorensen, L. B. 1965. Role of the intestinal tract in the elimination of uric acid. Arthritis and Rheumatism 8 (5):694–706. doi: 10.1002/art.1780080429.
   PubMedGoogle Scholar
• Tannahill, G. M., A. M. Curtis, J. Adamik, E. M. Palsson-McDermott, A. F. McGettrick, G. Goel, C. Frezza, N. J. Bernard, B. Kelly, N. H. Foley, et al. 2013. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496 (7444):238–42. doi: 10.1038/nature11986.
   PubMed Web of Science ®Google Scholar
• Togawa, N., T. Miyaji, S. Izawa, H. Omote, and Y. Moriyama. 2012. A Na+-phosphate cotransporter homologue (SLC17A4 protein) is an intestinal organic anion exporter. American Journal of Physiology. Cell Physiology 302 (11):C1652–60. doi: 10.1152/ajpcell.00015.2012.
   PubMed Web of Science ®Google Scholar
• Vibha, B., E. L. Richard, W. Wei, C. M. Nievergelt, M. S. Lipkowitz, J. Janina, A. X. Maihofer, and S. K. Nigam. 2016. Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: Potential role of remote sensing and signaling. Clinical Kidney Journal 9 (3):444–53. doi: 10.1093/ckj/sfw010.
   PubMed Web of Science ®Google Scholar
• Vieira, A. T., L. Macia, I. Galvão, F. S. Martins, M. C. C. Canesso, F. A. Amaral, C. C. Garcia, K. M. Maslowski, E. De Leon, D. Shim, et al. 2015. A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout. Arthritis & Rheumatology (Hoboken, N.J.) 67 (6):1646–56. doi: 10.1002/art.39107.
   PubMed Web of Science ®Google Scholar
• Wan, H., J. Han, S. Tang, W. Bao, C. Lu, J. Zhou, T. Ming, Y. Li, and X. Su. 2020. Comparisons of protective effects between two sea cucumber hydrolysates against diet induced hyperuricemia and renal inflammation in mice. Food & Function 11 (1):1074–86. doi: 10.1039/c9fo02425e.
   PubMed Web of Science ®Google Scholar
• Wang, H., L. Mei, Y. Deng, Y. Liu, X. Wei, M. Liu, J. Zhou, H. Ma, P. Zheng, J. Yuan, et al. 2019. Lactobacillus brevis DM9218 ameliorates fructose-induced hyperuricemia through inosine degradation and manipulation of intestinal dysbiosis. Nutrition (Burbank, Los Angeles County, Calif.) 62:63–73. doi: 10.1016/j.nut.2018.11.018.
   PubMed Web of Science ®Google Scholar
• Wang, Y., Z. Lin, B. Zhang, A. Nie, and M. Bian. 2017. Cichorium intybus L. promotes intestinal uric acid excretion by modulating ABCG2 in experimental hyperuricemia. Nutrition & Metabolism 14:38. doi: 10.1186/s12986-017-0190-6.
   PubMed Web of Science ®Google Scholar
• Wu, J., L. Qiu, X.-Q. Cheng, T. Xu, W. Wu, X.-J. Zeng, Y.-C. Ye, X.-Z. Guo, Q. Cheng, Q. Liu, et al. 2017. Hyperuricemia and clustering of cardiovascular risk factors in the Chinese adult population. Scientific Reports 7 (1):5456. doi: 10.1038/s41598-017-05751-w.
   PubMed Web of Science ®Google Scholar
• Xi, Y., J. Yan, M. Li, S. Ying, and Z. Shi. 2019. Gut microbiota dysbiosis increases the risk of visceral gout in goslings through translocation of gut-derived lipopolysaccharide. Poultry Science 98 (11):5361–73. doi: 10.3382/ps/pez357.
   PubMed Web of Science ®Google Scholar
• Xu, D., Q. Lv, X. Wang, X. Cui, P. Zhao, X. Yang, X. Liu, W. Yang, G. Yang, G. Wang, et al. 2019. Hyperuricemia is associated with impaired intestinal permeability in mice. American Journal of Physiology. Gastrointestinal and Liver Physiology 317 (4):G484–92. doi: 10.1152/ajpgi.00151.2019.
   PubMed Web of Science ®Google Scholar
• Xu, X. W., Y. F. Niu, L. H. Gao, L. Li, and H. Lin. 2018. Analysis of hypouricemic mechanism of mangiferin based on intestinal urate transporter ABCG2. Chinese Journal of Experimental Traditional Medical Formulae 24:145–149. doi: 10.13422/j.cnki.syfjx.20181733.
   Google Scholar
• Xu, X., C. Li, P. Zhou, and T. Jiang. 2016. Uric acid transporters hiding in the intestine. Pharmaceutical Biology 54 (12):3151–55. doi: 10.1080/13880209.2016.1195847.
   PubMed Web of Science ®Google Scholar
• Yamada, N., C. Iwamoto, H. Kano, N. Yamaoka, T. Fukuuchi, K. Kaneko, and Y. Asami. 2016. Evaluation of purine utilization by Lactobacillus gasseri strains with potential to decrease the absorption of food-derived purines in the human intestine. Nucleosides, Nucleotides & Nucleic Acids 35 (10–12):670–6. doi: 10.1080/15257770.2015.1125000.
   PubMed Web of Science ®Google Scholar
• Yano, H., Y. Tamura, K. Kobayashi, M. Tanemoto, and S. Uchida. 2014. Uric acid transporter ABCG2 is increased in the intestine of the 5/6 nephrectomy rat model of chronic kidney disease. Clinical and Experimental Nephrology 18 (1):50–5. doi: 10.1007/s10157-013-0806-8.
   PubMed Web of Science ®Google Scholar
• Yu, Y., Q. Liu, H. Li, C. Wen, and Z. He. 2018. Alterations of the gut microbiome associated with the treatment of hyperuricaemia in male rats. Frontiers in Microbiology 9:2233. doi: 10.3389/fmicb.2018.02233.
   PubMed Web of Science ®Google Scholar
• Yun, Y., H. Yin, Z. Gao, Y. Li, T. Gao, J. Duan, R. Yang, X. Dong, L. Zhang, and W. Duan. 2017. Intestinal tract is an important organ for lowering serum uric acid in rats. Plos One 12 (12):e0190194. doi: 10.1371/journal.pone.0190194.
   PubMed Web of Science ®Google Scholar
• Zhang, W., M. Doherty, E. Pascual, T. Bardin, V. Barskova, P. Conaghan, J. Gerster, J. Jacobs, B. Leeb, F. Liote, et al. 2006. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT). Annals of the Rheumatic Diseases 65 (10):1301–11. doi: 10.1136/ard.2006.055251.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., L. Jin, J. Li, W. Wang, H. Yu, J. Li, Q. Chen, and T. Wang. 2018. Effect and mechanism of dioscin from Dioscorea spongiosa on uric acid excretion in animal model of hyperuricemia. Journal of Ethnopharmacology 214:29–36. doi: 10.1016/j.jep.2017.12.004.
   PubMed Web of Science ®Google Scholar
• Zhou, Y., M. Zhao, Z. Pu, G. Xu, and X. Li. 2018. Relationship between oxidative stress and inflammation in hyperuricemia analysis based on asymptomatic young patients with primary hyperuricemia. Medicine 97 (49):e13108. doi: 10.1097/MD.0000000000013108.
   PubMed Web of Science ®Google Scholar